封面
市場調查報告書
商品編碼
1085427

計算生物學的全球市場:各類型(細胞、生物模擬,疾病建模、模擬應用),各工具,各地區-規模,佔有率,展望,機會分析(2022年~2028年)

Computational Biology Market, By Type (Cellular & Biological Simulation, Disease Modeling and Simulation Applications ), By Tools, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

生物資訊學工具的利用增加與研究開發的投資增加,預計促進在預測期間內的市場成長。再加上罹患慢性疾病的患者增加,及資料保存採用雲端運算,也預計促進市場成長。

本報告提供全球計算生物學市場的相關調查,市場展望,市場動態,市場分析,競爭情形等全面性資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各類型
    • 市場明細:各工具
    • 市場明細:各地區
    • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規情境
  • 合併和收購

第4章 全球計算生物學市場:各類型(100萬美元)(2017年~2028年)

  • 簡介
  • 細胞、生物模擬
  • 疾病建模、模擬應用

第5章 全球計算生物學市場:各工具(100萬美元)(2017年~2028年)

  • 簡介
  • 目錄/資料庫
  • 分析軟體和服務
  • IT基礎設施(硬體設備)

第6章 全球計算生物學市場:各地區(100萬美元)(2017年~2028年)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭情形

  • 企業簡介
    • Accelrys
    • Certara, LP
    • Chemical Computing Group Inc.
    • Compugen, ltd.
    • Entelos, Inc.(Rosa &Co. LLC)
    • Genedata AG
    • Insilico Biotechnology AG
    • Leadscope, Inc.
    • Nimbus Discovery LLC
    • Rhenovia Pharma SAS
    • Schrodinger
    • Simulation Plus, Inc.

第8章 Section

簡介目錄
Product Code: CMI3915

Computational Biology are used of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences. Predictive modeling tools provide vital information for better streamlining of drug development process thus reducing time and increasing efficiency. Increasing use of bioinformatics tools along with increasing investment in research and development is expected to propel the market growth during the forecast period. Furthermore, increasing patient population suffering from chronic diseases, increasing adoption of cloud computing for data storage is also anticipated to assist the growth of the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Computational Biology market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Computational Biology market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Computational Biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Computational Biology market

Detailed Segmentation:

  • Global Computational Biology Market, By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
  • Global Computational Biology Market, By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
  • Global Computational Biology Market, By Region:
  • North America
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Accelrys *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Certara, L.P.
  • Chemical Computing Group Inc.
  • Compugen, ltd.
  • Entelos, Inc. (Rosa & Co. LLC)
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Discovery LLC
  • Rhenovia Pharma SAS
  • Schrodinger
  • Simulation Plus, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Tools
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Computational Biology Market, By Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cellular & Biological Simulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
  • Disease Modeling and Simulation Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Drug Discovery
    • Drug Development

5. Global Computational Biology Market, By Tools, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Content/Database
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Analysis Software & Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • IT Infrastructure (Hardware)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Computational Biology Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • Accelrys
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Certara, L.P.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chemical Computing Group Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Compugen, ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Entelos, Inc. (Rosa & Co. LLC)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Genedata AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Insilico Biotechnology AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Leadscope, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Nimbus Discovery LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rhenovia Pharma SAS
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Schrodinger
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Simulation Plus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact